Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector

Sort by: Date|Relevance

Beyond Meat Bounces Back from Sharp Decline with New 'Meatier' Burger Patty

Plant-based meat company Beyond Meat has had a volatile week, with share price dropping 25% on Tuesday. But things may be looking up again for this vegan protein producer, with shares bouncing back 12.6% on Wednesday, following the announcement of a new product. ...

I'm Mad as Hell: Long Live Howard Beale

In the 1976 movie "Network," British actor Peter Finch won an Academy Award for his stunning portrayal of news anchorman Howard Beale, whose on-air descent into insanity, prompted by the social and economic conditions of the times, is now legendary. The iconic scene whe...

Gold and Silver: Capitulation Time

"People everywhere are being fed propaganda, lies and false stimuli of all kinds, but deep in their hearts, deep in their instincts, they know something is wrong."—G. Edward Griffin, author of The Creature from Jekyll Island My usual weekend missive was mildly delay...

Nowhere to Hide

As I begin the weekly missive here on Thursday, the U.S. equity markets are experiencing the worst daily assault since that fateful day back in 1987, when the Dow lost 23% in a single trading session, sending thousands of Gucci-clad stockbrokers to the Sears re-fit aisle....

Vivus Shares Climb 50% Higher on sNDA Approval for Exocrine Pancreatic Insufficiency Drug

Shares of Vivus traded higher after the FDA approved the company's supplemental New Drug Application for an improved formulation of PANCREAZE® (pancrelipase) for use in the treatment of exocrine pancreatic insufficiency due to cystic fibrosis and other conditions. ...

BARDA Award Provides 'Lift-off for Biotech's COVID Vaccine'

The ways in which Moderna is to use the funds are explained and an update on its coronavirus vaccine is provided in a ROTH Capital Partners report. In an April 19 research note, ROTH Capital Partners analyst Yasmeen Rahimi reported that the Biomedical Advanc...

Technical Analyst Update on Black Tusk Resources

Technical analyst Clive Maund charts the explorer and discusses recent trading in the stock. Although our buying towards the end of May didn't succeed in triggering a breakout by Black Tusk Resources Inc. (TUSK:CSE; BTKRF:OTCMKTS; 0NB:FSE) , it rose a bit and it...

Aging in the New World Order of Managed Markets

After over 40 years in the world of money and markets, I have arrived at the conclusion that aging can be a double-edged sword where the advantages created by many years of experience are many times odiously offset by innate biases that become ingrained over time. It came...

Underowned and Underloved

Back in the Dark Ages, before cellular phones and the Internet, I was studying to complete the Ontario Securities course one afternoon when I came across the part discussing "asset allocation" and "portfolio construction." This section covered the recommended mix of bonds...

The Inflation–Deflation Conundrum

As I sit here on the shores of lovely Lake Scugog, its weed-infested waters lying in wait for countless unsuspecting propellers soon to be ensnared, I am reminded of the failed world of central banking and policy initiatives, which too has become ensnared in flora of its ...
1 2 3